课题基金 / 基金详情

Mechanotransduction in Aqueous Outflow Regulation and Open Angle Glaucoma

Mechanotransduction in Aqueous Outflow Regulation and Open Angle Glaucoma
房水流出调节和开角型青光眼中的机械传导
批准号:
10091442
负责人:
TED S ACOTT
金额:
$37.22万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2023-01-31

项目摘要

项目成果

TED S ACOTT的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 青光眼是全球不可逆转失明的主要原因。虽然这种疾病的病因很复杂, 它通常与眼压升高有关,这是由于对房水的抵抗力增加所致。 体液流出通过小梁网络(TM)。人类的TM大约要坚硬20倍 青光眼,提示TM机制生物学的重要作用。尽管目前的流出途径模型 据估计,TM的邻近区域贡献了90-95%的流出阻力,它是广泛的 承认外流本身在TM的周长上不是均匀的,但与 相对高流量(HF)和低流量(LF)的区域。尽管之前已经认识到了这一点,但几乎所有 过去几十年的研究基本上忽略了这一事实。是否存在内在的差异 HF和LF区以及非青光眼和青光眼患者之间的TM细胞尚不清楚。 支持这一提议的初步数据显示,对于青光眼组织,有更多的LF区域,他们 较硬,并与基质交联酶活性升高有关。相反,高频区域是 更柔软、更少,并且具有较低的交联度。基于这些和其他观察,我们有 假设在节段性流动区域之间存在细胞的先天差异,并且这些 直接调节细胞外基质(ECM)的周转、交联化和流出。精确的机械装置 这是向增加低频地区的相对转变的基础,目前尚不清楚。为了机械地理解 调节基质生物力学、成分和节段性流出之间的联系,我们将使用两种一般方法 实验方法,(A)使用灌流的人眼前节器官培养,我们将比较 HF和LF区的生物力学和生化特性,测量交联度,并从 这些;和(B)使用细胞衍生矩阵来确定细胞-基质相互作用。具体来说,在目标1中,我们将 从青光眼和非青光眼TM的不同流动区分离TM细胞,对细胞进行鉴定 表面受体的分布,并研究其对生物物理刺激的机械转导反应。我们 还将获得和表征细胞来源的细胞外基质,并确定这些细胞外基质对细胞的影响 行为。在目标2中,我们将确定和量化ECM交联链的性质,记录 交联酶活性,并确定抑制交联剂是否会改变生物力学和成分 正常眼和青光眼的节段性区域。我们还将确定底物是否 生物力学调节节段性流动细胞的交联性。最后,在目标3中,我们将使用有针对性的 确定动态平衡反应的调节器并操纵流出区的方法。尤其是我们 将针对细胞外基质结合整合素α7β1在调节流出、细胞外基质重塑和 节段性血流的变化。这些目标的实现将揭示TM细胞-ECM相互作用的机制 并确定新的靶点,通过增加活跃的流出面积来降低高眼压,并治疗青光眼。
英文摘要
PROJECT SUMMARY Glaucoma is a leading cause of irreversible blindness worldwide. While the etiology of the disease is complex, it is typically associated with elevated intraocular pressure (IOP) due to increased resistance to aqueous humor outflow through the trabecular meshwork (TM). The human TM is approximately 20 fold stiffer in glaucoma, suggesting a prominent role of TM mechanobiology. Although current outflow pathway models estimate that the juxtacanalicular region of the TM contributes to 90-95% of the outflow resistance, it is widely accepted that outflow itself is not uniform around the circumference of the TM, but is highly segmental with regions of relatively high flow (HF), and low flow (LF). Although this has been recognized previously, nearly all studies over the past few decades have essentially ignored this fact. Whether there are inherent differences in TM cells of HF and LF regions and between non-glaucomatous and glaucomatous individuals remains unclear. Preliminary data in support of this proposal shows that, with glaucoma tissues, there are more LF regions, they are stiffer, and are associated with elevated matrix crosslinking enzyme activity. Conversely, HF regions are softer, fewer, and have lower levels of crosslinking activity. Based on these and other observations, we have hypothesized that there are innate differences in cells between the segmental flow regions, and these directly regulate extracellular matrix (ECM) turnover, crosslinking, and outflow. The precise mechanism that underlies the relative shift to increased LF regions is unclear. In order to mechanistically understand the regulatory link between matrix biomechanics, composition, and segmental outflow, we will use two general experimental approaches, (A) using perfused human anterior segment organ culture, we will compare biomechanical and biochemical properties of HF and LF regions, measure crosslinking, and, isolate cells from these; and (B) use cell derived matrices to determine cell-matrix interactions. Specifically, in Aim 1, we will isolate TM cells from different flow regions of glaucomatous and non-glaucomatous TM, characterize cell surface receptor distribution, and investigate their mechanotransduction response to biophysical stimuli. We will also obtain and characterize cell derived ECM, and determine the effect that these ECM have on cellular behavior. In Aim 2, we will ascertain and quantify the nature of ECM crosslinks, document differences in crosslinking enzyme activity, and determine if inhibiting crosslinks changes the biomechanics and composition of segmental regions in both normal and glaucomatous eyes. We will also determine if substratum biomechanics modulates crosslinking in segmental flow cells. Finally, in Aim 3, we will use a targeted approach to identify regulators of the homeostatic response and manipulate outflow regions. Particularly we will target the specific role that ECM binding integrin α7β1 has in mediating outflow, ECM remodeling, and shifts in segmental flow. Accomplishment of these aims will reveal a mechanism for TM cell-ECM interactions and identify novel targets to reduce elevated IOP by increasing areas of active outflow, and treat glaucoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Aqueous Humor Outflow Resistance
The Aqueous Humor Outflow Resistance
The Aqueous Humor Outflow Resistance
Molecular Mechanisms of Outflow Segmentation and Intraocular Pressure Homeostasis
海外基金